Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
07 November 2014 09:36
Researchers have developed a new drug for asthma patients
Researchers have developed a drug that offers new hope to those suffering from asthma or chronic obstructive pulmonary disease (COPD).
The new medicine, called RPL554, works by blocking two enzymes in the body and can help to relax the airway muscles as well as reducing inflammation in sufferers.
Experts say the drug could revolutionise the treatment of asthma and COPD as it does not have any of the substantial side effects of current treatments.
A new treatment with minimal side-effects could encourage asthma sufferers to travel more - however before doing so they should be sure to arrange asthma travel insurance.
A trial carried out across three countries - the UK, the Netherlands and Italy - found that RPL554 relieves patients of symptoms and also has an an ti-inflammatory effect.
After a week of treatment, COPD patients were able to forcibly exhale a 17% higher volume of air after breathing in deeply than before.
The researchers said participants in the trial - both the placebo group and sufferers - had a good tolerance of the drug, and only mild side effects were noted.
RPL554 treatment also did not cause any of the stomach issues linked to current asthma and COPD drugs.
Treatments for these conditions have remained largely the same for the past four decades, although experts started to doubt their effectiveness after they were found to worsen asthma symptoms and fail to protect from flare ups.
What the experts at Asthma UK say
Dr Samantha Walker, director of research and policy at Asthma UK, described the new drug as "unique" because it has two effects at the same time.
She said the 250,000 people in the UK with severe asthma urgently need better medication, adding that current treatments come with a range of "unwelcome side effects" such as osteoporosis, sleep problems, weight gain and depression.
Asthma UK will watch the development of RPL554 "with great interest", Dr Walker said.
The findings of the study have been published in the journal The Lancet Respiratory Medicine.
23 September 2016
Theresa May is being urged to give the go-ahead for flights to resume between the UK and Sharm el-Sheikh by the head of the cross-party parliamentary group on Egypt.
22 September 2016
Budget airline Jet2.com is to open its first base in the south of England at Stansted.
21 September 2016
Smoking rates have dropped to the lowest level on record in England, new figures show, suggesting messages about the health effects of cigarettes are hitting home.
20 September 2016
Concerns have been raised over flight disruptions caused by heavy drinking among passengers.
17 September 2016
British Airways' decision to launch direct flights from London to Tehran earlier this month positions Iran as one of the hottest destinations to visit in 2017, according to experts.
16 September 2016
More than 100 flights have been cancelled as French air traffic controllers go on strike again.
15 September 2016
Two thirds of MPs would support an expansion at Heathrow.
14 September 2016
TripAdvisor is launching a new homepage, making the booking of holiday activities and tours even easier.
13 September 2016
Travellers are to be charged to use fast lanes to get through passport checks in an attempt to cut queues.
09 September 2016
People travelling to regions affected by the Zika virus outbreak should practise safe sex for at least half a year upon their return, health leaders say.
08 September 2016
British Airways is apologising to passengers for delays after an IT glitch hit check-in systems.
07 September 2016
Tiny particles that are breathed in and taken into the brain through air pollution could trigger Alzheimer's disease, research finds.